| 1 | India | 1.27% | |
| 2 | Early | 1.27% | |
| 3 | Total | 1.27% | |
| 4 | HIV | 1.27% | |
| 5 | Pain | 1.27% | |
| 6 | Bicara | 0.63% | |
| 7 | Childhood | 0.63% | |
| 8 | Testing | 0.63% | |
| 9 | Measles | 0.63% | |
| 10 | Reduce | 0.63% | |
| 11 | Mediterranean | 0.63% | |
| 12 | Women’s | 0.63% | |
| 13 | Tumors | 0.63% | |
| 14 | Cryotherapy | 0.63% | |
| 15 | Allergy | 0.63% | |
| 16 | $1B | 0.63% | |
| 17 | Cefazolin | 0.63% | |
| 18 | Proteins | 0.63% | |
| 19 | Risk | 0.63% | |
| 20 | Vaccine | 0.63% | |
| 21 | MIND | 0.63% | |
| 22 | Africa’s | 0.63% | |
| 23 | Detection | 0.63% | |
| 24 | Network | 0.63% | |
| 25 | Study | 0.63% | |
| 26 | Fibrosis | 0.63% | |
| 27 | Global | 0.63% | |
| 28 | Outbreak | 0.63% | |
| 29 | Age | 0.63% | |
| 30 | Emphysema | 0.63% | |
| 31 | Fight | 0.63% | |
| 32 | Accelerated | 0.63% | |
| 33 | Overlapping | 0.63% | |
| 34 | Atypical | 0.63% | |
| 35 | Pneumonia | 0.63% | |
| 36 | Pharmacogenomics | 0.63% | |
| 37 | Transcatheter | 0.63% | |
| 38 | Prevalence | 0.63% | |
| 39 | Safe | 0.63% | |
| 40 | Outcomes | 0.63% | |
| 41 | Doubling | 0.63% | |
| 42 | Eosinophilic | 0.63% | |
| 43 | UB | 0.63% | |
| 44 | Integration | 0.63% | |
| 45 | Relieved | 0.63% | |
| 46 | Merus | 0.63% | |
| 47 | JAA | 0.63% | |
| 48 | Stymieing | 0.63% | |
| 49 | #ASCO25 | 0.63% | |
| 50 | OB/GYN | 0.63% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||